Jack Lin
Stock Analyst at Morgan Stanley
(0.48)
# 3,998
Out of 4,355 analysts
24
Total ratings
27.8%
Success rate
-11.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Lin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCM HUTCHMED (China) | Upgraded: Hold | $14 → $14 | $11.45 | +18.78% | 3 | May 28, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Upgraded: Buy | $19.60 → $17.00 | $11.63 | +46.17% | 3 | May 28, 2026 | |
| HKG: 0013 HUTCHMED (China) Limited | Maintained: Sell | $21.40 → $21.45 | $18.32 | +17.09% | 2 | Mar 6, 2026 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Maintained: Buy | $493.00 | $225.60 | +118.53% | 2 | Nov 20, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $215.00 | $118.10 | +82.05% | 3 | Nov 9, 2025 | |
| HKG: 9688 Zai Lab Limited | Maintained: Buy | $37.50 → $37.44 | $13.91 | +169.16% | 2 | Nov 6, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Hold | $89.00 | $82.65 | +7.68% | 2 | Oct 30, 2025 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $123.00 | $83.35 | +47.57% | 1 | Sep 22, 2025 | |
| HKG: 1952 Everest Medicines Limited | Maintained: Hold | $55.00 | $30.14 | +82.48% | 1 | Sep 22, 2025 | |
| HKG: 2162 Keymed Biosciences Inc. | Maintained: Buy | $93.50 | $61.80 | +51.29% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $48 | $17.69 | +171.34% | 3 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22.00 | $9.75 | +125.64% | 1 | Sep 19, 2025 |
HUTCHMED (China)
May 28, 2026
Upgraded: Hold
Price Target: $14 → $14
Current: $11.45
Upside: +18.78%
InnoCare Pharma Limited
May 28, 2026
Upgraded: Buy
Price Target: $19.60 → $17.00
Current: $11.63
Upside: +46.17%
HUTCHMED (China) Limited
Mar 6, 2026
Maintained: Sell
Price Target: $21.40 → $21.45
Current: $18.32
Upside: +17.09%
Duality Biotherapeutics, Inc.
Nov 20, 2025
Maintained: Buy
Price Target: $493.00
Current: $225.60
Upside: +118.53%
Akeso, Inc.
Nov 9, 2025
Maintained: Buy
Price Target: $215.00
Current: $118.10
Upside: +82.05%
Zai Lab Limited
Nov 6, 2025
Maintained: Buy
Price Target: $37.50 → $37.44
Current: $13.91
Upside: +169.16%
RemeGen Co., Ltd.
Oct 30, 2025
Maintained: Hold
Price Target: $89.00
Current: $82.65
Upside: +7.68%
Innovent Biologics, Inc.
Sep 22, 2025
Maintained: Buy
Price Target: $123.00
Current: $83.35
Upside: +47.57%
Everest Medicines Limited
Sep 22, 2025
Maintained: Hold
Price Target: $55.00
Current: $30.14
Upside: +82.48%
Keymed Biosciences Inc.
Sep 22, 2025
Maintained: Buy
Price Target: $93.50
Current: $61.80
Upside: +51.29%
Sep 21, 2025
Maintained: Buy
Price Target: $50 → $48
Current: $17.69
Upside: +171.34%
Sep 19, 2025
Maintained: Buy
Price Target: $22.00
Current: $9.75
Upside: +125.64%